Bio-microfluidic devices incorporating microscale features ranging from tens to hundreds of micrometers offer precise control over fluid dynamics and cell culture conditions within confined environments. These capabilities facilitate the recreation of physiologically relevant microenvironments and enable high-sensitivity biological analyses, finding broad utility in applications such as cell culture, tissue modeling, and diagnostics [1–6]. In recent years, the growing accessibility and resolution of 3D printing technologies have driven increased interest in their use for microfluidic device fabrication. Two predominant approaches have emerged: (i) direct fabrication of microfluidic structures via 3D printing, and (ii) indirect fabrication, wherein a 3D-printed mold is used to replicate structures in polydimethylsiloxane (PDMS).
While direct printing offers design flexibility and rapid prototyping, it is often hindered by challenges such as cytotoxicity of photopolymer resins and autofluorescence that interferes with optical imaging [7–9]. In contrast, PDMS, commonly used in indirect molding, is highly suitable for biological applications due to its biocompatibility, optical transparency, gas permeability, and low autofluorescence [10, 11]. Accordingly, indirect molding using 3D-printed molds has gained prominence for cell culture applications. However, challenges remain in optimizing the mold surface to ensure compatibility with PDMS curing and cell experiments.
Photopolymerization-based 3D printing, including stereolithography (SLA), constructs complex three-dimensional structures layer-by-layer from 3D-CAD data. Although conventional photolithography remains the gold standard for microfabrication, it requires cleanroom facilities, expensive equipment, and trained personnel, and is limited in geometrical complexity. In contrast, SLA-based desktop 3D printers offer low-cost, rapid fabrication of intricate designs, democratizing access to microfabrication by enabling reproducibility through shareable digital files. While high-resolution systems such as two-photon polymerization can achieve submicron precision [12], their high cost and low throughput limit their utility for routine biological experimentation. SLA printers thus strike a practical balance between resolution, speed, and cost, making them attractive for fabricating cell culture devices [13].
Nevertheless, 3D-printed molds present two key issues that limit their integration with PDMS: (i) inhibition of PDMS curing due to residual photoinitiators and additives leaching from the resin, and (ii) anisotropic surface roughness, particularly vertical stepping artifacts from the layer-by-layer process, which can influence cellular behavior [14]. To address curing inhibition, various resin-specific post-treatments and surface coatings such as parylene deposition have been explored [15, 16]. Meanwhile, the mitigation of surface roughness—especially in the Z-direction—has garnered attention for its importance in cell-microenvironment interactions [17].
In this study, we introduce a surface modification strategy for 3D-printed molds using polyvinyl alcohol (PVA) dip coating. PVA, a water-soluble, biodegradable, and non-toxic polymer derived from the hydrolysis of polyvinyl acetate, is widely employed in biomedical, packaging, and electronic industries due to its excellent film-forming properties, strong adhesion, and compatibility with biological systems [18–24]. By dip-coating 3D-printed molds with PVA, we aim to simultaneously suppress PDMS curing inhibition and reduce surface roughness (Fig. 1). The PVA film serves as a physical barrier, preventing direct contact between PDMS and the inhibitory resin surface, while also filling micro-grooves generated during printing to enhance smoothness.
Dip coating is a widely utilized thin-film deposition technique, wherein a substrate is immersed in a coating solution and withdrawn vertically at a controlled rate, followed by solvent evaporation or film curing. The film thickness obtained can be predicted by classical models such as the Landau–Levich–Derjaguin equation, which relates film thickness to surface tension, viscosity, density, gravitational acceleration, and withdrawal speed [25–29]. Importantly, the water solubility of PVA allows for facile removal after PDMS molding, ensuring the native surface properties of PDMS are retained, which is useful for biological applications.
We first characterize the relationship between PVA concentration, viscosity, and resulting film thickness, then assess the effectiveness of the coating in mitigating PDMS curing inhibition and improving mold surface smoothness. To validate the utility of this method for biological applications, we fabricate PDMS-based microwell arrays using PVA-coated 3D-printed molds and evaluate their performance in the formation of embryoid bodies (EBs) from induced pluripotent stem (iPS) cells.
iPS cells are stem cells established by reprogramming somatic cells and characterized by their capacity for self-renewal and pluripotency to differentiate into the three primary germ layers—ectoderm, mesoderm, and endoderm. iPS cell technology offers significant advantages over ES cells, such as overcoming ethical concerns and avoiding immune rejection through autologous transplantation. Consequently, iPS cells are highly anticipated for applications in regenerative medicine, drug screening, and disease modeling [30–33]. The formation of EBs is a widely employed intermediate step for directing the differentiation of iPS cells into specific cell types. EBs are 3D aggregates formed by self-organization of iPS cells, providing an in vitro environment that recapitulates early embryogenesis. Therefore, this process is a critical stage in efficient differentiation protocols for obtaining target cells and organoids [34–36]. Uniform EB formation is critical for reproducibility, and microwell-based techniques—wherein cells sediment and aggregate in confined wells—have proven effective for generating homogeneous EBs [37–39].
In this study, we demonstrate the fabrication of such microwell structures using our PVA-coated mold strategy and evaluate their performance in EB formation, thereby underscoring the potential of this approach to enhance the utility of 3D-printed molds in microfluidic and cell culture applications.